Crystal Structure of an LSD-Bound Human Serotonin Receptor

Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., ... & Shoichet, B. K. | Cell | 26 January 2017

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects

Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, D. V., ... & Liechti, M. E. | Journal of neuroendocrinology | 1 January 2017

Harmine stimulates proliferation of human neural progenitors

Dakic, V., de Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. | PeerJ | 6 December 2016

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT

Ma, K. H., Liu, T. T., Weng, S. J., Chen, C. F. F., Huang, Y. S., Chueh, S. H., ... & Huang, W. S. | Scientific Reports | 1 December 2016

Ecstasy research: will increasing observational data aid our understanding of MDMA?

Amoroso, T. | The Lancet Psychiatry | 1 December 2016

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. | International Journal of Molecular Sciences | 23 November 2016

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016

Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016

Rehabilitating LSD history in postwar America: Dilworth Wayne Woolley and the serotonin hypothesis of mental illness

Hewitt, K. | History of Science | 2 November 2016

MOLECULAR DOCKING STUDIES ON THE THERAPEUTIC TARGETS OF ALZHEIMER DISEASE (ACHE AND BCHE) USING NATURAL BIOACTIVE ALKALOIDS

Jyothi, P., & Yellamma, K. | International Journal of Pharmacy and Pharmaceutical Sciences | 1 November 2016

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction

Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. | Frontiers in Neuroscience | 14 September 2016

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., ... & Iosifescu, D. V. | Neuropsychopharmacology | 8 September 2016

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies

Vegting, Y., Reneman, L., & Booij, J. | Psychopharmacology | 28 August 2016

The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. | Journal of Psychopharmacology | 25 August 2016

The antidepressant effect of ketamine: Mediated by AMPA receptors?

Inta, D., Sprengel, R., Borgwardt, S., Lang, U. E., & Gass, P. | European Neuropsychopharmacology | 20 August 2016

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. | Pharmacological Research | 17 August 2016

Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study

Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016

New use for an old drug: oral ketamine for treatment-resistant depression

Swiatek, K. M., Jordan, K., & Coffman, J. | BMJ Case Reports | 3 August 2016

Neurovascular Plasticity of the Hippocampus One Week after a Single Dose of Ketamine in Genetic Rat Model of Depression

Ardalan, M., Wegener, G., Polsinelli, B., Madsen, T. M., & Nyengaard, J. R. | Hippocampus | 21 July 2016

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R. and Strassman, R. | Frontiers in Pharmacology | 30 June 2016